Telstar completes the expansion of Merck’s biotechnological manufacturing plant in Madrid

by Telstar

The complete execution of the project, developed under the EPCM (Engineering, Procurement and Construction Management) contract model, has been carried out by Telstar. The company has developed the ba...

Read more

El CIPF reúne a casi 200 expertos en el desarrollo de fármacos más eficaces contra el cáncer, la esclerosis y el Alzheimer

by Centro de Investigación Príncipe Felipe

Químicos, farmacéuticos, médicos y otros profesionales de distintas ramas se dan cita, por quinta vez, en el Centro de Investigación Príncipe Felipe. El simposio pretende, además ...

Read more

Abiertos cinco ensayos clínicos para paliar crisis epilépticas en niños con enfermedades raras

by Clínica Universidad de Navarra

Especialistas de la Clínica Universidad de Navarra ponen en marcha investigaciones para frenar estos síntomas en menores con síndrome de Dravet, síndrome Lennox-Gastaut y esclerosis tuberosa.

Read more

Avances en investigación básica sobre las resistencias a los antibióticos

by Universidad de Oviedo

El hallazgo, que ha sido publicado en la revista ‘Scientific Reports', ha sido posible gracias a la utilización del nuevo microscopio láser confocal de la Universidad

Read more

Cancer Research Technology and Pangaea Biotech sign license agreement to develop new cancer drugs

by Pangaea Biotech

CANCER Research Technology (CRT), the development and commercialisation arm of Cancer Research UK – has entered into a license agreement with Pangaea Biotech to develop p21-activated kinase (PAK) in...

Read more

Farmaindustria refuerza su compromiso con la transparencia aprobando la publicación individualizada de las transferencias de valor a profesionales sanitarios

by Farmaindustria

Farmaindustria celebró hoy en Barcelona su Asamblea General Ordinaria, clausurada por el President de la Generalitat, Carles Puigdemont, durante la cual se aprobaron la memoria anual de actividades y...

Read more

PRECIPITA selects UAB Alzheimer's disease crowdfunding project

by Universitat Autònoma de Barcelona (UAB)

PRECIPITA is the crowdfunding platform of the Spanish Foundation for Science and Technology (FECYT). It has selected a project by Professor Sandra Villegas to develop a drug based on the fragment of a...

Read more

MetaboStem uses computational design to develop cancer treatments

by Mind the Byte

The biotechnology company MetaboStem, a spin-off of the Catalan Institute of Oncology (ICO), has signed an agreement with Mind the Byte to offer tailor-made computational services to develop antitumou...

Read more

nLife Therapeutics appoints Dr. Errol B. De Souza as Executive Chairman

by nLife Therapeutics

​nLife Therapeutics, an early-stage biopharmaceutical company leading developments in conjugated nucleic acids as therapeutic agents for central nervous system (CNS) and neuromuscular (NS) disorders...

Read more

Un 50 por ciento de pacientes con cáncer de hígado avanzado sobrevive más de un año tras el tratamiento con inmunoterapia

by Clínica Universidad de Navarra

Según los resultados preliminares de un ensayo clínico fase I-II, liderado por investigadores de la Clínica Universidad de Navarra, en el que se probó la seguridad y la eficacia del fármaco nivol...

Read more

Clinical trial opens new avenues for pharmacological therapy in Down’s syndrome

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Though not a cure, this is the first time that a treatment has shown some effectiveness in this syndrome, and it opens the door to new research geared towards treating what was believed to be orphan o...

Read more

Nalmefene, the drug used for the treatment of alcoholism, shows to be effective also under the effects of cocaine

by UPF - Universitat Pompeu Fabra

A study recently published in the British Journal of Pharmacology involving Rafael Maldonado, professor of Pharmacology at Pompeu Fabra University, shows that nalmefene reduces the craving for alcohol...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

A chip against chronic bacterial infecti...

by IBEC - Institut de Bioenginyeria de Catalunya

IBEC researchers develop a device that allows to grow biofilms and ana...

Photos Stream